A brighter outlook? Optometry and an ageing population
8 February 2023
Winter 2023
In the second part of our series looking at the impact of ageing, Léa Suruge asks how to support older patients whose quality of life has been affected by age-related eye disease, and reviews the treatments available.
Brian Brown, 79, was diagnosed with wet age-related macular degeneration (AMD) 10 years ago. “I used to be a table tennis player, but I couldn’t see the ball or the lines on the table any more, so I had to stop. And I’ve been unable to drive for the last year, as I cannot read a licence plate up to 20 metres away. Giving up my driving licence has been difficult to accept.”
Living with his wife in High Wycombe and volunteering as treasurer of the local Macular Society group, Brian still leads an active social life. But his condition has affected his independence. To get into the clinic every six weeks for his anti-VEGF (vascular endothelial growth factors) injection, he must now take a taxi or rely on his son to drive him.
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people, which is predicted to rise by 100,000 cases to 1.145 million people by 2030*.
The government has progressed its commitment to moving more care from hospitals to communities.
The College of Optometrists has published its first issue of Ophthalmic and Physiological Optics (OPO), its flagship international and interdisciplinary research journal for contemporary vision science and optometry, with its new publishing partner Springer Nature this month.